The Biological Seed Treatment Market was valued at US$634.138 million in 2018 and is projected to expand at a CAGR of 12.94% over the forecast period to reach US$1316.302 million by 2024. Biological seed treatment is done to protect the seeds from pathogens. It leads to improved seeds which can cope not only with pests and diseases but also with unfavorable environmental conditions such as stress and nutrient-poor soil leading to increased productivity. The Biological Seed Treatment market is expected to have a significant growth rate due to environment-friendly, reduces the use of harmful chemicals and increased crop productivity. Huge investment has been made by the major players in the market which is expected to further fuel the market growth. But strict government rules and regulations regarding seed treatment can be a restraint for market growth. By crop, the corn segment is estimated to have a significant market share due to major industrial applications of corn and a number of pathogens affect the corn crop. By geography, North America is expected to have a significant market share due to restriction on the use of chemicals.
Adoption of sustainable agricultural practices
Huge investment made by private and public sector in research and development
Strict government rules and regulations
In December 2018 BASF expanded its soybean seed treatment portfolio with the launch of Vault® IP Plus seed treatment and Obvius® Plus fungicide seed treatment, recently registered by the Environmental Protection Agency (EPA). Both products will be commercially available in September 2019
Bayer completed the acquisition of Monsanto in June 2018. Monsanto BioAg products now rebranded as Acceleron BioAg
The Biological seed treatment Market has been analyzed through the following segments:
Middle East and Africa